
--- Item 2.02.    Results of Operations and Financial Condition. ---

Item 2.02.    Results of Operations and Financial Condition.
On February 4, 2026, LifeVantage Corporation (the “Company”)  issued a press release announcing its financial results for the three and six months ended December 31, 2025. A copy of the Company’s press release is attached as Exhibit 99.1 to this report and incorporated by reference.
The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

--- Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. ---

Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 30, 2026, Steven R. Fife notified the Company's board of directors (the “Board”) of his decision to retire as President and Chief Executive Officer and from the Board, with such resignation expected to be effective in April 2026. Mr. Fife’s decision to retire is not the result of any disagreement with the Company on any matter relating to the Company's operations, financial policies or practices.
More information on Mr. Fife’s retirement can be found in the press release furnished as Exhibit 99.2 to this current report on Form 8-K and incorporated herein by reference.

--- Item 9.01.    Financial Statements and Exhibits. ---

Item 9.01.    Financial Statements and Exhibits.
(d)    Exhibits
Exhibit No.
Description
99.1
Press Release issued by the Company on
February
4
, 202
6
, announcing its financial results for the three
and
six
months ended
December 31
, 2025.
99.2
Press Release issued by the Company on February 4, 2026, announcing Mr. Fife's retirement.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date:
February 4, 2026
By:
LIFEVANTAGE CORPORATION
/s/ Carl A. Aure
Name:
Carl A. Aure
Title:
Chief Financial Officer
EX-99.1
2
earningsrelease_q2fy26.htm
EX-99.1
Document
LifeVantage Announces Financial Results for the
Second Quarter of Fiscal 2026
Announces New $60 Million Share Repurchase Authorization
Salt Lake City, UT,
February 4, 2026
, LifeVantage Corporation (Nas
daq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2025.
Second Quarter Fiscal 2026 Summary*:
•
Revenue was $48.9 million, a decrease of 27.8% from the prior year period. Revenue was up 2.9% sequentially from the first quarter.
•
Revenue in the Americas decreased 32.6%, and revenue in Asia/Pacific & Europe decreased 2.1%.
•
Net income per diluted share was $0.02, versus $0.19 per diluted share a year ago;
•
Adjusted earnings per diluted share
was $0.15, c
ompared to
$0.22
a year ago; and
•
Adjusted EBITDA was $3.9 million compared to $6.5 million a year ago.
* All comparisons are on a year over year basis and compare the second quarter of fiscal 2026 to the second quarter of fiscal 2025, unless otherwise
noted.
"The second quarter reflected challenging competitive dynamics in the weight loss market as we cycled the launch of our MindBody GLP-1 System™ in October 2024," said Steve Fife, President and CEO of LifeVantage. “We acknowledge that our performance during the quarter did not meet your expectations or ours and we are redoubling our efforts to stabilize our GLP-1 business and make the other changes necessary to return to revenue growth.
